Dapagliflozin reduced the combined risk of worsening heart failure
Dapagliflozin reduced the combined risk of worsening heart failure or cardiovascular death among patients with heart failure and a mildly reduced or preserved ejection fraction.
CARDIOLOGY
Cardiovascular System : Physical Examination – III
Cardiovascular System : Physical Examination -III
Cardiovascular System : Physical Examination – II
Cardiovascular System : Physical Examination – II ANSWER THE QUESTION TO PROCEED FURTHER
